Search bioRxiv⌕ Search

Biology subjects

Reid, B. M.

Publications and source records attributed to Reid, B. M..

2 recordsLinked to original sources

Functional Data Analysis of Spatial Clustering Identifies Prognostic T Cell Patterns in Ovarian Cancer

Spatial proteomic imaging technologies enable the simultaneous assessment of immune cell abundance and spatial organization within the tumor microenvironment. Spatial clustering is commonly summarized using measures such as Ripleys K or nearestOneighbor G-functions at a fixed radius. However, these approaches depend on scale selection and may obscure biologically relevant patterns occurring across spatial ranges. We propose a functional data analysis (FDA) framework to model spatial clustering trajectories derived across a continuum of radii. Functional principal component analysis (FPCA) was used to summarize dominant modes of spatial variation, and resulting scores were incorporated into Cox proportional hazards models as both main effects and interaction with immune cell abundance. The approach was applied to multiplex immunofluorescence data from five ovarian cancer studies, comprising 773 highOgrade ovarian serous tumors. Analyses focused on CD3+ and CD8+ T cell populations within the tumor compartment of the tissue, adjusting for age at diagnosis and cancer stage, with study-specific estimates combined using random-effects meta-analysis. Higher abundance of both T cells and CD8+ T cells was consistently associated with improved overall survival. Beyond abundance, spatial features captured by the leading functional principal component were independently associated with survival, particularly for CD8+ T cells. Interaction models further showed that the prognostic effect of immune infiltration depended on spatial clustering, with tumors characterized by high abundance and low spatial clustering exhibiting the most favorable outcomes. These findings indicate that spatial organization provides complementary prognostic information beyond abundance alone and suggests that more diffuse immune infiltration may reflect more effective anti-tumor activity in ovarian cancer. Overall, FDA offers a flexible and interpretable framework for modeling spatial clustering across scales and identifying prognostic spatial features not captured by fixed-radius or distance analyses.

cancer biology↗

Utilizing Digital Pathology to Quantify Stromal Caveolin-1 Expression in Malignant and Benign Ovarian Tumors: Associations with Clinicopathological Parameters and Clinical Outcomes

Loss of stromal caveolin-1 (Cav-1) is a biomarker of a cancer-associated fibroblast (CAF) phenotype and is related to progression, metastasis, and poor outcomes in several cancers. The objective of this study was to evaluate the clinical significance of Cav-1 expression in invasive epithelial ovarian cancer (OvCa). Epithelial and stromal Cav-1 expression were quantified in serous OvCa and benign ovarian tissue in two, independent cohorts - one quantified expression using immunohistochemistry (IHC) and the other using multiplex immunofluorescence (IF) with digital image analysis designed to target CAF-specific expression. Cav-1 expression was significantly downregulated in OvCa stroma compared to non-neoplastic stroma using both the IHC (p=0.002) and IF (p=1.8x10-13) assays. OvCa stroma showed Cav-1 downregulation compared to tumor epithelium with IHC (p=1.2x10-24). Conversely, Cav-1 expression was higher in OvCa stroma compared to tumor epithelium with IF (p=0.002). There was moderate correlation between IHC and IF methods for stromal Cav-1 expression (r2= 0.69, p=0.006) whereas there was no correlation for epithelial expression (r2=0.006, p=0.98). Irrespective of the staining assay, neither response to therapy or overall survival correlated with the expression level of Cav-1 in the stroma or tumor epithelium. Our findings demonstrate a loss of stromal Cav-1 expression in ovarian serous carcinomas. Studies are needed to replicate these findings and explore therapeutic implications, particularly for immunotherapy response.

cancer biology↗